![[Important Notice] Porton Announcement Regarding The Change Of Email Domain](/Data/File/@W700/427-01.jpg "[Important Notice] Porton Announcement Regarding The Change Of Email Domain")
Your current status
- Necessary
- Analytics
- Targeting
Show details
SHARE
30.04.2024
Porton 2023 ESG Report
SHARE
Driving innovation and excellence in the CDMO industry, Porton Pharma Solutions 2024 CPHI Europe Review
Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals
Porton Will Be Participating In Biotech Outsourcing Strategies Events This June
Proton At CPhI North America Again
Porton 2023 ESG Report
Upcoming Porton Shows In Europe And The USA：Shaping Our Future Together
Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development
Join Our Founder And CEO @ DCAT Week
Porton Pharma Solutions Joined The SBTi To Drive Climate Action
Farewell To 2023, And WE Are Sailing Forward To 2024
The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia.
Porton Gets Improved In The 2023 S&P Global ESG Score
Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services
Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023
[Important Notice] Porton Announcement Regarding The Change Of Email Domain
Porton Unveils Its Small Molecule Platform Headquarters In Shanghai
PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai
Porton At DCAT Week 2023: A Highly Successful And Strategic Event
Porton Released 2022 CSR Report
Porton Delivers Strong 2022 Performance With 127% Sales Growth
Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score